menu search

Emergent BioSolutions Reports Financial Results for Second Quarter 2023

Emergent BioSolutions Reports Financial Results for Second Quarter 2023
Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and provides initial Q3 2023 forecast for total revenues GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter […] The post Emergent BioSolutions Reports Financial Results for Second Quarter 2023 appeared first on ForexTV... Read More
Posted: Aug 8 2023, 20:31
Author Name: forextv
Views: 022239

Search within

Pages Search Results: